Clinical Trials Browser

Phase 2 × NETWORK × trametinib × Clear all

NCT05518110 2026-04-13

PaTcH

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT02974803 2021-08-20

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Phase 2 Terminated

6 enrolled 3 charts

CNSDermatologic

Brain Neoplasms, Melanoma